koah akut atağında farklı steroid dozlarının solunum fonksiyonları ...

22. Saetta M, Di Stefano A, Turato G, et al. CD8 T-lymphocytes in peripheral airways of smokers
with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 822–826.
23. Rennard SI. Inflammation and repair processes in chronic obstructive pulmonary disease. Am J
Respir Crit Care Med 1999; 160: S12–S16.
24. Peinado VI, Barbera JA, Abate P, et al. Inflammatory reaction in pulmonary muscular arteries of
patients with mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159:
1605–1611.
25. Rodriguez-Roisin R, MacNee W. Pathophysiology of chronic obstructive pulmonary disease. Eur
Respir Mono 1998; 3: 107–126.
26. O’Shaughnessy TC, Ansari TW, Barnes NC, Jeffery PK. Inflammation in bronchial biopsies of
subjects with chronic bronchitis: inverse relationship of CD8 T lymphocytes with FEV 1 . Am J
Respir Crit Care Med 1997; 155: 852–857.
27. Repine JE, Bast A, Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease.
Oxidative Stress Study Group. Am J Respir Crit Care Med 1997; 156: 341–357.
28. Matsuba K, Wright JL, Wiggs BR, Pare PD, Hogg JC. The changes in airways structure
associated with reduced forced expiratory volume in one second. Eur Respir J 1989; 2: 834–839.
29. O’Donnell DE, Revill SM, Webb KA. Dynamic hyperinflation and exercise intolerance in
chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 770–777.
30. Pare PD, Wiggs BR, James A, et al. The comperative mechanics and morphology of airways in
asthma and chronic obstructive pulmonary disease. Am Rev Respir Dis 1991; 143: 1189-1193.
31. Quanjer PH, TammelingGJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Eur
Respir J 1993; 6 ( Suppl 16 ): 5-40.
32. Siafakas NM, ve ark. Optimal assessment and management of chronic obstructive pulmonary
disease (COPD). ERS Consensus Statement. Eur Respir J 1995; 8: 1398-1420.
33. BTS Guidelines for the Management of Chronic Obstructive Pulmonary Disease. The COPD
Guidelines Group of the Standards of Care Committee of the BTS. Thorax 1997; 52:1-26.
34. The GOLD Global strategy for the management and prevention of COPD. www.goldcopd.com
35. McCrory DC, Brown C, Gelfand SE, Bach PB. Management of acute exacerbations of COPD. A
summary and appraisal of published evidence. Chest 2001; 119: 1190-1209.
36. Ferrer M, Alonso J, Morera J, et al. Chronic obstructive pulmonary disease and health related
quality of life. Ann Int Med 1997; 127: 1072–1079.
37. Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA, Maslen TK. Randomised, double
blind, placebo controlled study of fluticasone propionate in patients with moderate to severe
chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 2000; 320: 1297–1303.
38. Dewan N, Rafique S, Kanwar B, et al. Acute exacerbation of COPD. Factors associated with poor
treatment outcome. Chest 2000; 117: 662–671.
39. Anthonisen NR, Wright EC, Hodgkin JE, the IPPB Trial Group. Prognosis in chronic obstructive
pulmonary disease. Am Rev Respir Dis 1986; 133: 14–20.
40. Celli B, Halbert R, Isonaka S, Schau B. Population impact of different definitions of airway
obstruction. Eur Respir J 2003; 22: 268–273.
41. Schols AM, Slangen J, Volovics L, Wouters EF. Weight loss is a reversible factor in the
prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157:
1791–1797.
42. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in
chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: 1856–1861.
43. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than
airway obstruction in patients with COPD. Chest 2002; 121: 1434–1440.
44. Emerman CL, Cydulka RK. Evaluation of high-yield criteria for chest radiography in acute
exacerbation of chronic obstructive pulmonary disease. Ann Emerg Med 1993;22(4):680–684.
45. O’Brien C, Guest PF. Physiological and radiological characterization of patients diagnosed with
chronic obstructive pulmonary disease in primary care. Thorax 2000; 55: 631–632.
46. Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest 2000,
117:398S–401S.
47. Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic
obstructive pulmonary disease. Ann Intern Med 1987; 106: 196–204.
48. Lung and Asthma Information Agency. Trends in emergency hospital admissions for lung
disease. Fact sheet 2001/4. London: St George’s Hospital Medical School.
57